Associated Papers
Interaction of cardiac leiomodin with the native cardiac thin filament.
Little M et al.
Plos Biology, 2025
Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunction.
Iwanski JB et al.
Npj Regenerative Medicine, 2024
Human disease-causing mutations result in loss of leiomodin 2 through nonsense-mediated mRNA decay.
Pappas CT et al.
Plos Genetics, 2024
Lmod2 is necessary for effective skeletal muscle contraction.
Larrinaga TM et al.
Science Advances, 2024
Diagnostic Yield of Exome Sequencing in Pediatric Cardiomyopathy.
Keisling J et al.
The Journal of Pediatrics, 2024
Whole-Exome Sequencing Identifies Homozygote Nonsense Variants in LMOD2 Gene Causing Infantile Dilated Cardiomyopathy.
Sono R et al.
Cells, 2023
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.
Lipov A et al.
Nature Cardiovascular Research, 2023
38666070 (PubMed )
Supplement: 44161_2023_346_MOESM1_ESM.pdf
LMOD2-related dilated cardiomyopathy presenting in late infancy.
Lay E et al.
American Journal of Medical Genetics. Part A, 2022
Neonatal-lethal dilated cardiomyopathy due to a homozygous LMOD2 donor splice-site variant.
Yuen M et al.
European Journal of Human Genetics : Ejhg, 2022
Early Death of 2 Siblings Related to Mutations in LMOD2, a Recently Discovered Cause of Neonatal Dilated Cardiomyopathy.
Greenway SC et al.
Cjc Open, 2021
Redefining actin dynamics of the pointed-end complex in striated muscle.
Iwanski J et al.
Trends in Cell Biology, 2021
In vivo elongation of thin filaments results in heart failure.
Mi-Mi L et al.
Plos One, 2020
Disruption of cardiac thin filament assembly arising from a mutation in LMOD2: A novel mechanism of neonatal dilated cardiomyopathy.
Ahrens-Nicklas RC et al.
Science Advances, 2019
Select a paper to view details